BDBM3193 (+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-methylpropyl]oxy]carbonyl]phenyl]carbonyl]-3-hydroxybenzoic Acid::2-{[2,6-dihydroxy-4-({[4-(4-hydroxyphenyl)butan-2-yl]oxy}carbonyl)phenyl]carbonyl}-3-hydroxybenzoic acid::Acyclic Balanol Analog 21b

SMILES CC(CCc1ccc(O)cc1)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(O)=O)c(O)c1

InChI Key InChIKey=TXVBBLNFLUZGIT-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 3193   

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 410nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 40nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 5.00E+4nMAssay Description:The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 250nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 280nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3193((+-)-2-[[2,6-Dihydroxy-4-[[[3-(4-hydroxyphenyl)-1-...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed